Angelini Pharma

Nice to meet you!

Health EN ↓ 7 episodes

Nice to meet you! is a podcast created to give voice to Angelini Pharma Leaders. The stories about their job, vision and commitment in the company. The Italian journalist, Barbara Serra, will interview them starting with the question: "Did you always want to do what you do now or were your plans different before?”. #AngeliniPharma #EveryStepCloser #EmployerBranding #CompanyLife

Be sure to visit the podcast's website and support the creator: www.spreaker.com

Author

Angelini Pharma

Category

Health

Podcast website

www.spreaker.com

Latest episode

Jan 9, 2024

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Enza Onnis: unveil 3-decade insights into pharmaceutical legal dynamics 09.01.2024

Enza Maria Cristina Onnis, Global General Counsel at Angelini Pharma, in this podcast shares insights of her over three decades of invaluable experience at Angelini Pharma. In this interview, we will have the opportunity to discover the intricacies of her role, the unique challenges of the pharmaceutical legal landscape as well as the difficulties involved in navigating the complexities of the glo...

Erik Lommerde: from local to global, how commerciale strategy changes 11.10.2023

Discover the role of the International Chief Commercial Operations Officer by tuning in to our interview with Erik Lommerde. In this episode, we uncover Erik Lommerde's professional journey, delving into the diverse challenges, the weight of responsibilities, and the exciting opportunities encountered by those dedicated to driving success in international commercial operations.

Patrizia Ciavatta: How to register a drug 05.07.2023

Patrizia Ciavatta, Global Regulatory and Pharmacovigilance Chief, explains how she got to her role and what makes her everyday job so special. In this interview we will have the opportunity to explore the challenges, responsibilities, and opportunities that professionals in the field face on a daily basis in ensuring safety, efficacy, and adherence to regulations regarding pharmaceutical products.

Fabrizio Caranci: Digital Innovation in the pharmaceutical sector 06.02.2023

How a Digital innovation is possible in Healthcare System? Fabrizio Caranci, Global Digital Medicines Executive Director, explains how Angelini Pharma is promoting a digital culture between its people to take care of people.

Gabriele Ghirlanda: How is the value of a drug determined? 12.01.2023

Gabriele Ghirlanda, Global Access and Value Chief at Angelini Pharma, talks about his work and explains at what stage of drug development he intervenes, who are the key stakeholders with whom he interfaces, both inside and outside the company. He describes, as well, the process that leads pharmaceutical companies and Health Technology Assessment (HTA) bodies to determine the value of a drug and it...

Agnese Cattaneo: From to cure to care 12.12.2022

Agnese Cattaneo, explains what is the most interesting part of her job as Chief Medical Officer at Angelini Pharma and how the multinational pharmaceutical company compare with patients, considering that nowadays these are always more active, informed and involved in their therapeutic journeys. From to cure to care, she explains how is the role of Angelini Pharma in improving people’s quality of l...

Rafal Kaminski: How a drug is born 23.11.2022

How does a drug idea come about? Rafal Kaminski, Chief Scientific Officer of Angelini Pharma, explains the main steps of the drug development process and the changes that are taking place as a result of technological progress.

Listen to the Nice to meet you! podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.